San Juan, Puerto Rico

Linette Castillo-pichardo

This inventor holds 1 USPTO granted patent. Top assignee: University of Puerto Rico. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Linette Castillo-pichardo. Retrieved from https://idiyas.com/inventor/linette-castillo-pichardo-615cktt4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Linette Castillo-Pichardo: Patent Inventor in San Juan, Puerto Rico.

Introduction

Linette Castillo-Pichardo is an inventor associated with San Juan, Puerto Rico, and the University of Puerto Rico. Her patent work concerns compounds that target signaling proteins involved in cancer and other hyperproliferative diseases.

Latest Patents

Castillo-Pichardo is named on 1 patent: “1,5-Disubstituted 1,2,3-Triazoles Are Inhibitors of RAC/CDC42 GTPases.” The patent describes compounds that inhibit the Rho GTPases Rac and Cdc42, which can be overactive or overexpressed in cancer-related signaling pathways. It also discusses potential methods for treating cancer and other hyperproliferative diseases.

Career Highlights

Her documented patent contribution focuses on chemical compounds designed to inhibit Rac and Cdc42 activity. The disclosed research connects these targets with cancer and metastasis-related pathways.

Collaborations

The patent information provided associates Castillo-Pichardo with the University of Puerto Rico. No additional collaborators are specified in the supplied details.

Conclusion

Linette Castillo-Pichardo’s patent work, associated with the University of Puerto Rico, explores inhibitors of Rac and Cdc42 as potential tools for addressing cancer and other hyperproliferative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…